Pemphigoid Antibody Panel - Epithelial Basement Membrane Zone Antibodies, IgG and IgA, BP180 and BP230 Antibodies, IgG
• Antibody panel for initial diagnostic assessment and disease monitoring in pemphigoid, epidermolysis bullosa acquisita, and linear IgA bullous dermatosis. Bullous pemphigoid and other pemphigoid variants, epidermolysis bullosa acquisita (EBA), and linear IgA bullous dermatosis present with blistering, erosions, pruritus, and urticaria, which affect skin and mucous membranes.
• Panel components include IgG and IgA epithelial BMZ antibodies and IgG bullous pemphigoid BP 180 and 230 antigens. To order individual component tests, refer to Epithelial Basement Membrane Zone Antibody IgG (0092056), Epithelial Basement Membrane Zone Antibody IgA (0092057), and/or Bullous Pemphigoid Antigens (180 kDa and 230 kDa), IgG (0092566).
• Preferred panel is Basement Membrane Zone Antibody Panel (3001410), which also includes extended testing for EBA with the Collagen Type VII Antibody IgG by ELISA.
• To screen for pemphigoid along with other possible immunobullous diseases, order concurrently with Pemphigus Antibody Panel - Epithelial Cell Surface Antibodies and Desmoglein 1 and Desmoglein 3 Antibodies, IgG (0090650), Collagen Type VII Antibody IgG by ELISA (2010905), AND Cutaneous Direct Immunofluorescence, Biopsy (0092572).
Enzyme-Linked Immunosorbent Assay/Indirect Fluorescent Antibody
Plain red or serum separator tube.
Transfer 2 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Hemolyzed or lipemic specimens.
Ambient: 1 week; Refrigerated: 2 weeks; Frozen: Indefinitely
No compliance statements are in use for this test.
For specimens less than 0.5 mL, call the Immunodermatology Laboratory at (866) 266-5699.
88346; 88350 x2; 83516 x2
|Component Test Code*||Component Chart Name||LOINC|
|0092002||Pemphigoid Antibody Panel||48767-8|
|2010914||EER Pemphigoid Antibody Panel||11526-1|
- Bullous Pemphigoid